Amgen, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 2.85%140.140.0%$919.45m
AMGNAmgen, Inc. 0.74%249.341.5%$835.12m
GILDGilead Sciences, Inc. 0.35%64.061.0%$543.88m
VRTXVertex Pharmaceuticals, Inc. 3.84%268.531.9%$479.71m
REGNRegeneron Pharmaceuticals, Inc. 2.80%679.642.6%$433.91m
ILMNIllumina, Inc. 0.15%243.863.3%$314.28m
NVAXNovavax, Inc. -0.51%53.1575.7%$305.95m
BIIBBiogen, Inc. 0.82%201.291.8%$242.02m
BNTXBioNTech SE 1.44%165.350.0%$229.68m
SNSSSunesis Pharmaceuticals, Inc. -0.95%2.090.7%$146.10m
EXASEXACT Sciences Corp. -2.26%51.9717.7%$143.77m
TECHBio-Techne Corp. -1.22%361.884.5%$99.57m
BMRNBioMarin Pharmaceutical, Inc. 1.12%80.614.2%$99.50m
NKTXNkarta, Inc. 0.12%12.690.0%$99.42m
TXG10X Genomics, Inc. -2.12%49.100.0%$99.14m

Company Profile

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, Aimovig, KANJINTI, EVENITY, AMGEVITA, AVSOLA, BLINCYTO, MVASI, Corlanor, Enbrel, EPOGEN, IMLYGIC, Kyprolis, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, Otezla, RIABNI, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.